Oxford University Hospitals NHS Foundation Trust, Department of Cardiology, John Radcliffe Hospital, Oxford, United Kingdom.
Oxford University Hospitals NHS Foundation Trust, Department of Cardiology, John Radcliffe Hospital, Oxford, United Kingdom.
JACC Clin Electrophysiol. 2017 Apr;3(4):367-373. doi: 10.1016/j.jacep.2016.09.016. Epub 2016 Nov 30.
This study reports on the safety of early removal of pericardial drains after cardiac tamponade complicating atrial fibrillation catheter ablation (AFCA) procedures, the need for repeat pericardiocentesis, major adverse outcomes, as well as length of stay, and the need for opiate analgesia.
Tamponade from AFCA is traditionally managed by pericardiocentesis with delayed removal of the drain (typically 12 to 24 h later) in case of re-bleeding. A drain in situ often causes severe pain but ongoing blood loss is rare. Our institution adopted the practice of early removal of drains before leaving the laboratory if bleeding has stopped.
The authors performed a retrospective descriptive analysis of 43 cases of tamponade complicating AFCA from 2006 to 2015, comparing patients in whom the drain was removed early (group early removal [ER]; n = 25) versus traditional delayed removal (group delayed removal [DR]; n = 18).
The groups were similar with respect to clinical/demographic characteristics, proportions of first-time versus re-do and pulmonary vein isolation versus pulmonary vein isolation + additional ablation. There were no deaths. No ER patients required drain re-insertion before discharge. The length of stay was shorter in the ER group (3 days; range 1 to 9 days) than in the DR group (4 days; range 2 to 60 days). The requirement for opiate analgesia was less in the ER group (8%) than in the DR group (72%).
Early removal of pericardial drains after tamponade complicating AFCA procedures appears to be safe and effective, with re-insertion not required in this cohort. The traditional practice of leaving drains in situ for 12 to 24 h may result in more patient discomfort and longer hospitalization.
本研究报告了心房颤动导管消融(AFCA)术后并发心脏压塞时早期拔除心包引流管的安全性,包括重复心包穿刺的需求、主要不良结局、住院时间以及阿片类镇痛药的需求。
AFCA 引起的心包填塞传统上通过心包穿刺治疗,并在再次出血时延迟拔除引流管(通常在 12 至 24 小时后)。引流管原位常引起严重疼痛,但持续失血很少见。本机构采用的做法是,如果出血停止,在离开实验室前早期拔除引流管。
作者对 2006 年至 2015 年期间 43 例 AFCA 并发心脏压塞的病例进行了回顾性描述性分析,比较了引流管早期拔除(早期拔除组 [ER],n=25)与传统延迟拔除(延迟拔除组 [DR],n=18)的患者。
两组在临床/人口统计学特征、首次与再次、肺静脉隔离与肺静脉隔离+附加消融的比例方面相似。无死亡病例。无 ER 患者在出院前需要重新插入引流管。ER 组的住院时间较短(3 天;范围 1 至 9 天),而 DR 组(4 天;范围 2 至 60 天)较长。ER 组需要阿片类镇痛药的比例(8%)低于 DR 组(72%)。
AFCA 术后并发心脏压塞时早期拔除心包引流管似乎是安全有效的,在本队列中无需再次插入。传统上留置引流管 12 至 24 小时的做法可能会导致更多的患者不适和更长的住院时间。